Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

Por Jenke, Robert, Reßing, Nina, Hansen, Finn K., Aigner, Achim, Büch, Thomas
Publicado no Cancers (Basel) (2021)

Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity

Por Reßing, Nina, Marquardt, Viktoria, Gertzen, Christoph G. W., Schöler, Andrea, Schramm, Alexander, Kurz, Thomas, Gohlke, Holger, Aigner, Achim, Remke, Marc, Hansen, Finn K.
Publicado no Medchemcomm (2018)

Discovery of the first-in-class dual histone deacetylase-proteasome inhibitor

Por Bhatia, Sanil, Krieger, Viktoria, Groll, Michael, Osko, Jeremy D., Reßing, Nina, Ahlert, Heinz, Borkhardt, Arndt, Kurz, Thomas, Christianson, David W., Hauer, Julia, Hansen, Finn K.
Publicado no J Med Chem (2018)

Multicomponent synthesis, binding mode and structure-activity relationships of selective histone deacetylase 6 (HDAC6) inhibitors with bifurcated capping groups

Por Reßing, Nina, Sönnichsen, Melf, Osko, Jeremy D., Schöler, Andrea, Schliehe-Diecks, Julian, Skerhut, Alexander, Borkhardt, Arndt, Hauer, Julia, Kassack, Matthias U., Christianson, David. W., Bhatia, Sanil, Hansen, Finn K.
Publicado no J Med Chem (2020)